Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets
- PMID: 17902148
- DOI: 10.1002/ppul.20695
Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets
Abstract
Our aim was to evaluate if the combined inhalation of both nitric oxide (iNO) and aerosolized prostacyclin or iNO and adrenomedullin (ADM) is more effective in lowering pulmonary arterial pressure (PAP) and improving oxygenation than nitric oxide alone in an animal model with pulmonary hypertension (PH). Moreover, we studied the effect on pulmonary mechanics, surfactant activity, and pulmonary oxidative stress of the different treatments. Twenty-eight piglets with acute lung injury induced by lung lavages with saline were randomized to receive nitric oxide, nitric oxide plus prostacyclin, nitric oxide plus ADM or saline, after. Dynamic compliance, tidal volume, and airway resistance were measured. Lung tissue oxidation was evaluated by measuring total hydroperoxide and advanced oxidation protein products in bronchial aspirate samples. Surface surfactant activity was studied using Capillary Surfactometer. Inhaled nitric oxide combined with prostacyclin or ADM was more effective than nitric oxide alone in lowering PAP and improving oxygenation. Nitric oxide alone or combined increased lung compliance and tidal volume, and decreased airway resistance. No effects on surfactant surface activity and lung tissue oxidation were observed. The treatment with nitric oxide alone or combined with prostacyclin or ADM were effective in decreasing mean PAP and improving oxygenation in a piglet model of PH. However, nitric oxide plus prostacyclin and nitric oxide plus ADM were more effective than nitric oxide alone. The combination of aerosolized prostacyclin and ADM with nitric oxide might have a role in the treatment of infants with PH refractory to nitric oxide alone.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Inhaled nitric oxide for the adult respiratory distress syndrome.N Engl J Med. 1993 Feb 11;328(6):399-405. doi: 10.1056/NEJM199302113280605. N Engl J Med. 1993. PMID: 8357359 Clinical Trial.
-
Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion.J Pediatr Surg. 2001 Jul;36(7):980-4. doi: 10.1053/jpsu.2001.24721. J Pediatr Surg. 2001. PMID: 11431761
-
Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.Respir Med. 2005 Dec;99(12):1501-10. doi: 10.1016/j.rmed.2005.03.026. Respir Med. 2005. PMID: 15890512 Clinical Trial.
-
Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?Crit Care Clin. 2011 Jul;27(3):561-87. doi: 10.1016/j.ccc.2011.05.001. Crit Care Clin. 2011. PMID: 21742217 Review.
-
Inhaled nitric oxide in the adult respiratory distress syndrome and other lung diseases.New Horiz. 1993 Nov;1(4):638-50. New Horiz. 1993. PMID: 8087583 Review.
Cited by
-
Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice.Pulm Circ. 2019 Nov 15;9(4):2045894019881954. doi: 10.1177/2045894019881954. eCollection 2019 Oct-Dec. Pulm Circ. 2019. PMID: 31819797 Free PMC article.
-
Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists.Int J Mol Sci. 2022 Nov 2;23(21):13408. doi: 10.3390/ijms232113408. Int J Mol Sci. 2022. PMID: 36362188 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials